Global Information Inc. would like to present a new market research report, "U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012" by iData Research Inc..
U.S. Diabetes Diagnosis and Treatment Market to Surpass $17 Billion by 2018, Double-Digit Growth in Continuous Glucose Monitor, Insulin Pen and Insulin Pump Segments
Growth in the diabetes diagnosis, treatment and drug delivery market is expected to be fueled by a rising number of diabetics and improved education and awareness surrounding the importance of blood glucose management. Led by Novo Nordisk, Sanofi, Eli Lilly and Lifescan, the U.S. market for diabetes diagnosis, treatment and drug delivery is expected to surpass $17 billion by 2018. According to the iDatas new report, double-digit growth in the continuous glucose monitor, insulin pen and insulin pump segments will lead growth in the market.
This report provides detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limitations and a detailed competitive analysis. Manufacturer market shares and product portfolios are also included.
The report covers eight segments in the diabetes diagnosis, treatment and drug delivery market, including:
- Traditional blood glucose meters
- Blood glucose test strips
- Lancets and lancing devices
- Continuous glucose monitoring systems
- Insulin, insulin syringes, insulin pens and pumps